Mark Erlander, Founder of Cardiff Oncology

Mark Erlander is the founder of Cardiff Oncology. Cardiff Oncology has raised $200M in total funding. Latest round: Growth.

About Mark Erlander

Mark Erlander, Ph.D., is a biotech CEO specializing in oncology therapeutics. He formerly served as Chief Executive Officer of Cardiff Oncology, where he led the company through its name change and oversaw the advancement of its lead drug, onvansertib, through Phase 2 trials.

Mark Erlander at a glance

More founders in San Diego, California, United States (44)

Browse related founder lists (2)

Full founder directory · Investor directory · Company funding database · Fundraising library